Topic: Biotechnology
LONDON (Reuters) - British scientists have made the first human embryonic stem cells of a high enough grade to use in patients and deposited them in a public stem cell bank for development in human trials by drug companies and researchers by ...
The word's first artificial windpipe transplant has been such a success that a second operation has been carried out and a third is being planned, The Lancet reported on Thursday.Andemariam Teklesenbet Beyene, a 36-year-old Eritrean, is doing well after undergoing the ground-breaking ...
LONDON (Reuters) - Scientists are cooking up new ways of satisfying the world's ever-growing hunger for meat."Cultured meat" -- burgers or sausages grown in laboratory Petri dishes rather than made from slaughtered livestock -- could be the answer that feeds the world, ...
NEW YORK (Reuters) - The U.S. Food and Drug Administration appears to be on the verge of issuing long-awaiting guidelines for the development of generic versions of complex biotechnology medicines.The FDA still plans to release the guidance by the end of the ...
CHICAGO (Reuters) - Researchers have used patients' own cells to grow urinary tubes in the lab and have successfully used them to replace damaged tissue in five young boys, showing the potential power of cell-based therapies.Urine flow tests and tube diameter measurements ...
Japan's Fujifilm, which has been diversifying into healthcare, Monday said it would buy US and British biopharmaceutical companies from America's Merck for a reported half a billion dollars.The Japanese film and camera maker said that it would buy all shares of Diosynth ...
South Korea's biggest business group Samsung announced plans Friday for a $266 million pharmaceutical joint venture, as part of a ten-year multi-billion dollar attempt to develop new growth engines.Samsung said work would start in the first half of this year on a ...
IMAGINE taking a midnight stroll, your route lit by row upon row of trees glowing a ghostly blue. They emit light and are then converted into oxyluciferin, which cannot produce light. To counter this, the Cambridge team found a way to engineer ...
3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the results of its annual general meeting of shareholders held on October 29, 2010. At the meeting, the Company's shareholders re-elected Mr. Bin ...
The good news is that Richard Eno, the CEO of Metabolix, a publicly traded company (MBLX) based in Cambridge, Massachusetts, may have just the solution: In a joint venture with Archer Daniels Midland (ADM), Metabolix is pioneering the production of a family ...